Clinical study of Endostar plus capecitabine combined with stereotactic radiotherapy in the treatment of advanced pancreatic cancer subjects open, single group phase II

Trial Profile

Clinical study of Endostar plus capecitabine combined with stereotactic radiotherapy in the treatment of advanced pancreatic cancer subjects open, single group phase II

Completed
Phase of Trial: Phase II

Latest Information Update: 04 May 2016

At a glance

  • Drugs Endostatin (Primary) ; Capecitabine
  • Indications Pancreatic cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 02 May 2016 Status changed from recruiting to completed, as reported by Chinese Clinical Trial Registry.
    • 02 Jun 2015 Interim results in 13 patients presented at the 51st Annual Meeting of the American Society of Clinical Oncology.
    • 30 Oct 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top